Discover 878 paid clinical trials in Kentucky. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Kentucky presents diverse clinical research opportunities for healthy volunteers looking to get involved in paid studies, and those with specific health conditions alike. Major research centers in Louisville, Lexington, and Bowling Green are actively seeking participants, offering access to new treatments and advanced medical care.
Filter
1
Filter results
Results: 878
A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
for
Head and Neck Squamous Cell Carcinoma (HNSCC)
Location: Willow Grove PA, Richmond VA, Fairfax VA, Rochester NY,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06769698
Phase 2, Recruiting
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Halifax, Boston MA, Farmington CT, New Haven CT,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07258511
Phase 3, Recruiting
Testing the Addition of Cemiplimab (REGN2810) to Chemotherapy Treatment Given Prior to Surgery in Patients With Sinonasal Squamous Cell Carcinoma
for
Sinonasal Squamous Cell Carcinoma,
Location: Waterford CT, New Haven CT, Waterbury CT, Trumbull CT,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT07281417
Phase 2, Recruiting
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
for
Carcinoma, Non-Small-Cell Lung
Location: Boston MA, White Plains NY, Schenectady NY, Montreal,
Sponsor: Mirati Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT06875310
Phase 3, Recruiting
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
for
Locally Advanced Pancreatic Adenocarcinoma,
Location: Stamford CT, Millville DE, Lewes DE, Rehoboth Beach DE,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT06998940
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
for
Small Cell Lung Cancer
Location: Boston MA, Lebanon NH, Quebec, Lake Success NY,
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT06203210
Phase 3, Recruiting
Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
for
Hidradenitis Suppurativa (HS)
Location: St. John's, Boston MA, Farmington CT, Baltimore MD,
Sponsor: Incyte Corporation
Sex: All
Age: 12 - 17
Code: NCT07213973
Phase 2, Recruiting
Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design
for
Fibromyalgia
Location: Boston MA, Watertown MA, Cranston RI, Cromwell CT,
Sponsor: Axsome Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07398417
Phase 3, Recruiting
Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
for
Sickle Cell Disease Vaso-occlusive Crisis
Location: The Bronx NY, New York NY, Baltimore MD, Greenville NC,
Sponsor: CSL Behring
Sex: All
Age: 12+
Code: NCT06699849
Phase 2, Recruiting
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
for
Gastric Adenocarcinoma,
Location: Westerly RI, Waterford CT, Guilford CT, North Haven CT,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 18+
Code: NCT07001748
Phase 2, Phase 3, Recruiting
Augmented Renal Clearance in Neurocritical Care
for
TBI (Traumatic Brain Injury), Status Epilepticus,
Location: Columbus OH, Lexington KY, Edmonton
Sponsor: University of Alberta
Sex: All
Age: 18 - 70+
Code: NCT07410624
Recruiting
De-implementing Inhaled Nitric Oxide for Congenital Diaphragmatic Hernia
for
Congenital Diaphragmatic Hernia
Location: Boston MA, Charleston SC, Atlanta GA, Ann Arbor MI,
Sponsor: The University of Texas Health Science Center, Houston
Sex: All
Age: 0
Code: NCT05213676
Recruiting
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
for
Overweight, Obesity
Location: Boston MA, Waltham MA, New Haven CT, Waterbury CT,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07392190
Phase 3, Recruiting
A Study to Evaluate the Efficacy and Safety of Veverimer for the Treatment of Metabolic Acidosis
for
CKD, Metabolic Acidosis
Location: Fresh Meadows NY, New York NY, Newark DE, Margate FL,
Sponsor: Renibus Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07355062
Phase 3, Recruiting
Tasting Plant Forward Meals
for
Dietary Exposure
Location: Lexington KY
Sponsor: Sara Maksi
Sex: All
Age: 18 - 25
Code: NCT07202988
Recruiting
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)